Under the background of the reform and upgrading of the medical system, the problem of compliance management in the production/management of medical devices has become increasingly prominent. In the process of dynamic inspection, the focus of the supervision of the drug regulatory department on the enterprise will penetrate into all links of the life cycle, strengthen the supervision during and after the event, NMPA establishes a team of full-time inspectors to carry out daily follow-up inspection of the enterprise, and “flight inspection” has become the norm.